Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
Harry J Iland, John F Seymour
CURRENT TREATMENT OPTIONS IN ONCOLOGY | SPRINGER | Published : 2013
H.J. Iland: Provided expert testimony to Phebra, received payment for development of educational presentations from Novartis and Elsevier, and had conference accommodation expenses covered by Roche; J.F Seymour: Consultancy for Phebra.